Globus Medical Inc (GMED)

26.33
0.33 1.30
NYSE : Health Care
Prev Close 26.00
Open 26.05
Day Low/High 25.89 / 26.33
52 Wk Low/High 20.48 / 28.99
Volume 376.56K
Avg Volume 757.10K
Exchange NYSE
Shares Outstanding 95.51M
Market Cap 2.49B
EPS 1.20
P/E Ratio 21.33
Div & Yield N.A. (N.A)

Latest News

2 Fundamentally Strong Medical Device Stocks to Buy Now

2 Fundamentally Strong Medical Device Stocks to Buy Now

The health care sector is booming, but many stocks are overvalued. We pinpoint the best buys now in the medical device niche.

4 Medical Device Makers With Healthy-Looking Charts

4 Medical Device Makers With Healthy-Looking Charts

These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

Noteworthy Wednesday Option Activity: GMED, IMMR, BKS

Noteworthy Wednesday Option Activity: GMED, IMMR, BKS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Globus Medical Inc , where a total volume of 3,046 contracts has been traded thus far today, a contract volume which is representative of approximately 304,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 54.1% of GMED's average daily trading volume over the past month, of 563,450 shares.

Rival Offer for LDR Is Unlikely, but Never Say Never

Rival Offer for LDR Is Unlikely, but Never Say Never

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

Globus Medical (GMED) Stock Receives ‘Equal Weight’ Rating at Barclays

Globus Medical (GMED) Stock Receives ‘Equal Weight’ Rating at Barclays

Globus Medical (GMED) coverage was started with an ‘equal weight’ rating and $26 price target at Barclays.

Analysts' Actions -- J.C. Penney, Kohl's, Microsoft, Nokia and More

Analysts' Actions -- J.C. Penney, Kohl's, Microsoft, Nokia and More

Here are Monday's top research calls, including upgrades for J.C. Penney and Nokia, a downgrade for Kohl's and new coverage of Microsoft.

Globus Medical (GMED) Is Weak On High Volume Today

Globus Medical (GMED) Is Weak On High Volume Today

Trade-Ideas LLC identified Globus Medical (GMED) as a weak on high relative volume candidate

First Week of May 20th Options Trading For Globus Medical (GMED)

First Week of May 20th Options Trading For Globus Medical (GMED)

Investors in Globus Medical Inc saw new options become available this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new May 20th contracts and identified one put and one call contract of particular interest.

Globus Medical Reports Full Year And Fourth Quarter 2015 Results

Globus Medical Reports Full Year And Fourth Quarter 2015 Results

Record Sales and Profits

10 Stocks Billionaire John Paulson Is Buying for 2016

10 Stocks Billionaire John Paulson Is Buying for 2016

Here are 10 stocks hedge fund manager John Paulson has been buying lately, either initiating new stakes or upping his holdings significantly.

Interesting GMED Put And Call Options For September 16th

Interesting GMED Put And Call Options For September 16th

Investors in Globus Medical Inc saw new options become available this week, for the September 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Analysts' Actions -- Aetna, Cigna, Cirrus Logic, Foot Locker and More

Analysts' Actions -- Aetna, Cigna, Cirrus Logic, Foot Locker and More

Here are Friday's top research calls, including a downgrade for Aetna, and upgrades for Cigna, Cirrus Logic and Foot Locker.

DEADLINE APPROACHING: Marcus & Boxerman Announces Filing Of Securities Class Action Lawsuit Against Globus Medical, Inc. And Advises Investors With Losses In Excess Of 50,000 To Contact The Firm

DEADLINE APPROACHING: Marcus & Boxerman Announces Filing Of Securities Class Action Lawsuit Against Globus Medical, Inc. And Advises Investors With Losses In Excess Of 50,000 To Contact The Firm

Marcus & Boxerman announces that a securities class action lawsuit has been filed against Globus Medical, Inc.

Insider Trading Alert - GMED, ITG And TREE Traded By Insiders

Insider Trading Alert - GMED, ITG And TREE Traded By Insiders

Stocks with insider trader activity include GMED, ITG and TREE

IMPORTANT INVESTOR ALERT: Marcus & Boxerman Announces An Ongoing Investigation Of Globus Medical, Inc. And Encourages Investors To Contact The Firm

IMPORTANT INVESTOR ALERT: Marcus & Boxerman Announces An Ongoing Investigation Of Globus Medical, Inc. And Encourages Investors To Contact The Firm

Marcus & Boxerman announces that it is investigating claims of potential misrepresentations by Globus Medical, Inc.

Glancy Prongay & Murray LLP Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against Globus Medical, Inc.

Glancy Prongay & Murray LLP Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against Globus Medical, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors that  a class action complaint has been filed on behalf of a class of Globus Medical, Inc.